Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial

OBJECTIVE: To determine the effects of dapagliflozin in patients with heart failure (HF) and type 2 diabetes mellitus (T2DM) on left ventricular (LV) remodeling using cardiac MRI. RESEARCH DESIGN AND METHODS: We randomized 56 patients with T2DM and HF with LV systolic dysfunction to dapagliflozin 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Jagdeep S.S., Mordi, Ify R., Vickneson, Keeran, Fathi, Amir, Donnan, Peter T., Mohan, Mohapradeep, Choy, Anna Maria J., Gandy, Stephen, George, Jacob, Khan, Faisel, Pearson, Ewan R., Houston, J. Graeme, Struthers, Allan D., Lang, Chim C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Novel Communications in Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245350/
https://www.ncbi.nlm.nih.gov/pubmed/32245746
http://dx.doi.org/10.2337/dc19-2187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245350/
https://www.ncbi.nlm.nih.gov/pubmed/32245746
http://dx.doi.org/10.2337/dc19-2187

Ejemplares similares